Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Temozolomide-Capecitabine (TemCap) chemotherapy for Neuroendocrine Neoplasms (NENs): the dilemma of treatment duration.

Lamarca A, Barriuso J, McNamara MG, Hubner RA, Manoharan P, Mansoor W, Valle JW.

Neuroendocrinology. 2019 Sep 17. doi: 10.1159/000503392. [Epub ahead of print]

PMID:
31527383
2.

Spotlight on telotristat ethyl for the treatment of carcinoid syndrome diarrhea: patient selection and reported outcomes.

Saavedra C, Barriuso J, McNamara MG, Valle JW, Lamarca A.

Cancer Manag Res. 2019 Aug 8;11:7537-7556. doi: 10.2147/CMAR.S181439. eCollection 2019. Review.

3.

Outcomes in patients ≥ 80 years with a diagnosis of a hepatopancreaticobiliary (HPB) malignancy.

Lewis AR, Cipriano C, Wang X, Ward R, Fitzpatrick A, Scott ARM, Rashed A, Raja H, Lamarca A, Hubner RA, Valle JW, McNamara MG.

Med Oncol. 2019 Sep 6;36(10):85. doi: 10.1007/s12032-019-1310-0.

PMID:
31493088
4.

Duodenal neuroendocrine tumour associated with minimal change glomerulonephritis.

Montague E, Hockenhull K, Lamarca A, Al-Sayed T, Hubner RA.

BMJ Case Rep. 2019 Aug 30;12(8). pii: e227987. doi: 10.1136/bcr-2018-227987.

PMID:
31473631
5.

Structural Bases of Atypical Whisker Responses in a Mouse Model of CDKL5 Deficiency Disorder.

Pizzo R, Lamarca A, Sassoè-Pognetto M, Giustetto M.

Neuroscience. 2019 Aug 28. pii: S0306-4522(19)30606-2. doi: 10.1016/j.neuroscience.2019.08.033. [Epub ahead of print]

PMID:
31472213
6.

Unusual skull base metastasis from neuroendocrine tumor: a case report.

Lim KHJ, Valle JW, Lamarca A.

J Med Case Rep. 2019 Aug 30;13(1):273. doi: 10.1186/s13256-019-2214-5.

7.

Capecitabine and temozolomide in patients with advanced pulmonary carcinoid tumours.

Papaxoinis G, Kordatou Z, McCallum L, Nasralla M, Lamarca A, Backen A, Nonaka D, Mansoor W.

Neuroendocrinology. 2019 Aug 23. doi: 10.1159/000502864. [Epub ahead of print]

PMID:
31437838
8.

Systemic therapy of gallbladder cancer: review of first line, maintenance, neoadjuvant and second line therapy specific to gallbladder cancer.

Azizi AA, Lamarca A, Valle JW.

Chin Clin Oncol. 2019 Aug;8(4):43. doi: 10.21037/cco.2019.07.05. Epub 2019 Jul 23.

9.

Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pancreatic cancer.

Mohan S, Ayub M, Rothwell DG, Gulati S, Kilerci B, Hollebecque A, Sun Leong H, Smith NK, Sahoo S, Descamps T, Zhou C, Hubner RA, McNamara MG, Lamarca A, Valle JW, Dive C, Brady G.

Sci Rep. 2019 Aug 12;9(1):11610. doi: 10.1038/s41598-019-47489-7.

10.

Resolution of necrolytic migratory erythema with somatostatin analogue in a patient diagnosed with pancreatic glucagonoma.

Saavedra C, Lamarca A, Hubner RA.

BMJ Case Rep. 2019 Aug 10;12(8). pii: e229115. doi: 10.1136/bcr-2018-229115.

PMID:
31401568
11.

Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study.

Carmona-Bayonas A, Jiménez-Fonseca P, Lamarca Á, Barriuso J, Castaño Á, Benavent M, Alonso V, Riesco-Martínez MDC, Alonso-Gordoa T, Custodio A, Sánchez Cánovas M, Hernando Cubero J, López C, Lacasta A, Fernández Montes A, Marazuela M, Crespo G, Escudero P, Diaz JÁ, Feliciangeli E, Gallego J, Llanos M, Segura Á, Vilardell F, Percovich JC, Grande E, Capdevila J, Valle JW, García-Carbonero R.

J Clin Oncol. 2019 Aug 7:JCO1900980. doi: 10.1200/JCO.19.00980. [Epub ahead of print]

PMID:
31390276
12.

Tumour Growth Rate as a validated early radiological biomarker able to reflect treatment-induced changes in Neuroendocrine Tumours; the GREPONET-2 study.

Lamarca A, Ronot M, Moalla S, Crona J, Opalinska M, Lopez Lopez C, Pezzutti D, Najran P, Carvalho LFDP, Bezerra ROF, Borg P, Vietti Violi N, Vidal Trueba H, de Mestier L, Schaefer N, Baudin E, Sundin A, Costa FP, Pavel M, Dromain C.

Clin Cancer Res. 2019 Aug 2. pii: clincanres.0963.2019. doi: 10.1158/1078-0432.CCR-19-0963. [Epub ahead of print]

PMID:
31375514
13.

In the literature: June 2019.

Lamarca A, Gambardella V, Cejalvo JM, Fleitas-Kanonnikoff T, Cervantes A.

ESMO Open. 2019 Jun 20;4(3):e000547. doi: 10.1136/esmoopen-2019-000547. eCollection 2019. No abstract available.

14.

Advanced intrahepatic cholangiocarcinoma: post-hoc analysis of the ABC-01, -02 and -03 clinical trials.

Lamarca A, Ross P, Wasan HS, Hubner RA, McNamara MG, Lopes A, Manoharan P, Palmer D, Bridgewater J, Valle JW.

J Natl Cancer Inst. 2019 May 11. pii: djz071. doi: 10.1093/jnci/djz071. [Epub ahead of print]

PMID:
31077311
15.

Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)-The GREPONET Study.

Lamarca A, Crona J, Ronot M, Opalinska M, Lopez Lopez C, Pezzutti D, Najran P, Carvhalo L, Franca Bezerra RO, Borg P, Vietti Violi N, Vidal Trueba H, de Mestier L, Schaefer N, Sundin A, Costa F, Pavel M, Dromain C; Knowledge Network.

Oncologist. 2019 Mar 25. pii: theoncologist.2018-0672. doi: 10.1634/theoncologist.2018-0672. [Epub ahead of print]

PMID:
30910869
16.

Genotype-phenotype correlations in pheochromocytoma and paraganglioma.

Crona J, Lamarca A, Ghosal S, Welin S, Skogseid B, Pacak K.

Endocr Relat Cancer. 2019 Mar 1. pii: ERC-19-0024.R2. doi: 10.1530/ERC-19-0024. [Epub ahead of print]

PMID:
30893643
17.

Clinical presentation, diagnosis and staging of cholangiocarcinoma.

Forner A, Vidili G, Rengo M, Bujanda L, Ponz-Sarvisé M, Lamarca A.

Liver Int. 2019 May;39 Suppl 1:98-107. doi: 10.1111/liv.14086. Epub 2019 Mar 25. Review.

PMID:
30831002
18.

18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) for patients with biliary tract cancer: Systematic review and meta-analysis.

Lamarca A, Barriuso J, Chander A, McNamara MG, Hubner RA, ÓReilly D, Manoharan P, Valle JW.

J Hepatol. 2019 Jul;71(1):115-129. doi: 10.1016/j.jhep.2019.01.038. Epub 2019 Feb 21.

PMID:
30797051
19.

Identification of patients with pancreatic adenocarcinoma due to inheritable mutation: Challenges of daily clinical practice.

Fulton AJ, Lamarca A, Nuttall C, McCallum L, Pihlak R, O'Reilly D, Lalloo F, McNamara MG, Hubner RA, Clancy T, Valle JW.

World J Gastrointest Oncol. 2019 Feb 15;11(2):102-116. doi: 10.4251/wjgo.v11.i2.102.

20.

Carboplatin in Combination with Oral or Intravenous Etoposide for Extra-Pulmonary, Poorly-Differentiated Neuroendocrine Carcinomas.

Frizziero M, Spada F, Lamarca A, Kordatou Z, Barriuso J, Nuttall C, McNamara MG, Hubner RA, Mansoor W, Manoharan P, Fazio N, Valle JW.

Neuroendocrinology. 2019;109(2):100-112. doi: 10.1159/000497336. Epub 2019 Jan 21.

PMID:
30703770
21.

Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe.

Javed MA, Beyer G, Le N, Vinci A, Wong H, Palmer D, Morgan RD, Lamarca A, Hubner RA, Valle JW, Alam S, Chowdhury S, Ma YT, Archibugi L, Capurso G, Maisonneuve P, Neesse A, Sund M, Schober M, Krug S.

Pancreatology. 2019 Jan;19(1):97-104. doi: 10.1016/j.pan.2018.10.003. Epub 2018 Oct 15.

PMID:
30529068
22.

Urgent need for consensus: international survey of clinical practice exploring use of platinum-etoposide chemotherapy for advanced extra-pulmonary high grade neuroendocrine carcinoma (EP-G3-NEC).

Lamarca A, Frizziero M, Barriuso J, McNamara MG, Hubner RA, Valle JW.

Clin Transl Oncol. 2019 Jul;21(7):950-953. doi: 10.1007/s12094-018-1996-z. Epub 2018 Nov 30.

PMID:
30506132
23.

Sorafenib as first-line therapy in patients with advanced Child-Pugh B hepatocellular carcinoma-a meta-analysis.

McNamara MG, Slagter AE, Nuttall C, Frizziero M, Pihlak R, Lamarca A, Tariq N, Valle JW, Hubner RA, Knox JJ, Amir E.

Eur J Cancer. 2018 Dec;105:1-9. doi: 10.1016/j.ejca.2018.09.031. Epub 2018 Oct 29.

PMID:
30384012
24.

The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers.

Lamarca A, Galdy S, Barriuso J, Moghadam S, Beckett E, Rogan J, Backen A, Billington C, McNamara MG, Hubner RA, Cramer A, Valle JW.

PLoS One. 2018 Oct 18;13(10):e0206007. doi: 10.1371/journal.pone.0206007. eCollection 2018. Erratum in: PLoS One. 2019 Feb 15;14(2):e0212697.

25.

Biliary Tract Cancer: State of the Art and potential role of DNA Damage Repair.

Lamarca A, Barriuso J, McNamara MG, Valle JW.

Cancer Treat Rev. 2018 Nov;70:168-177. doi: 10.1016/j.ctrv.2018.09.002. Epub 2018 Sep 8. Review.

PMID:
30218788
26.

Somatostatin analogue-induced pancreatic exocrine insufficiency in patients with neuroendocrine tumors: results of a prospective observational study.

Lamarca A, McCallum L, Nuttall C, Barriuso J, Backen A, Frizziero M, Leon R, Mansoor W, McNamara MG, Hubner RA, Valle JW.

Expert Rev Gastroenterol Hepatol. 2018 Jul;12(7):723-731. doi: 10.1080/17474124.2018.1489232. Epub 2018 Jun 28.

PMID:
29923433
27.

Clinical and Pathologic Characteristics of Pulmonary Carcinoid Tumors in Central and Peripheral Locations.

Papaxoinis G, Lamarca A, Quinn AM, Mansoor W, Nonaka D.

Endocr Pathol. 2018 Sep;29(3):259-268. doi: 10.1007/s12022-018-9530-y.

28.

PD-L1 expression and presence of TILs in small intestinal neuroendocrine tumours.

Lamarca A, Nonaka D, Breitwieser W, Ashton G, Barriuso J, McNamara MG, Moghadam S, Rogan J, Mansoor W, Hubner RA, Clark C, Chakrabarty B, Valle JW.

Oncotarget. 2018 Feb 12;9(19):14922-14938. doi: 10.18632/oncotarget.24464. eCollection 2018 Mar 13.

29.

Evaluation of oral serum-derived bovine immunoglobulins in HIV-infected patients with chronic idiopathic diarrhea.

Asmuth DM, Hinkle JE, LaMarca A, Fichtenbaum CJ, Somsouk M, Utay NS, Shaw AL, Petschow BW, Detzel CJ, Weaver EM.

HIV Clin Trials. 2017 Nov-Dec;18(5-6):205-213. doi: 10.1080/15284336.2017.1401256.

30.

Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: an alternative to the current RECIST-defined response.

Lamarca A, Barriuso J, Kulke M, Borbath I, Lenz HJ, Raoul JL, Meropol NJ, Lombard-Bohas C, Posey J, Faivre S, Raymond E, Valle JW.

Br J Cancer. 2018 Jan;118(2):181-188. doi: 10.1038/bjc.2017.402. Epub 2017 Nov 21.

31.

Multicenter Evaluation of the Xpert MRSA NxG Assay for Detection of Methicillin-Resistant Staphylococcus aureus in Nasal Swabs.

Yarbrough ML, Warren DK, Allen K, Burkholder D, Daum R, Donskey C, Knaack D, LaMarca A, May L, Miller LG, Parenti DM, Peterson L, Tan TY, Widen R, Hernandez DR, Wolk DM, Burnham CA.

J Clin Microbiol. 2017 Dec 26;56(1). pii: e01381-17. doi: 10.1128/JCM.01381-17. Print 2018 Jan.

32.

A study of appendiceal crypt cell adenocarcinoma (so-called goblet cell carcinoid and its related adenocarcinoma).

Nonaka D, Papaxoinis G, Lamarca A, Fulford P, Valle J, Chakrabarty B.

Hum Pathol. 2018 Feb;72:18-27. doi: 10.1016/j.humpath.2017.08.005. Epub 2017 Aug 18.

PMID:
28823572
33.

New Horizons for Precision Medicine in Biliary Tract Cancers.

Valle JW, Lamarca A, Goyal L, Barriuso J, Zhu AX.

Cancer Discov. 2017 Sep;7(9):943-962. doi: 10.1158/2159-8290.CD-17-0245. Epub 2017 Aug 17. Review.

34.

Update on Treatment Options for Advanced Bile Duct Tumours: Radioembolisation for Advanced Cholangiocarcinoma.

Najran P, Lamarca A, Mullan D, McNamara MG, Westwood T, Hubner RA, Lawrence J, Manoharan P, Bell J, Valle JW.

Curr Oncol Rep. 2017 Jul;19(7):50. doi: 10.1007/s11912-017-0603-8. Review.

35.

The dark side of T1 non-appendiceal small bowel neuroendocrine tumors.

Salih Z, Lamarca A, Nonaka D, Hubner RA, de Liguori-Carino N, McNamara MG, Fulford P, Minicozzi A, O'Dwyer S, Chakrabarty B, Valle JW.

Hum Pathol. 2017 Aug;66:239-240. doi: 10.1016/j.humpath.2017.02.030. Epub 2017 May 9. No abstract available.

PMID:
28499547
36.

Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.

Chiramel J, Backen AC, Pihlak R, Lamarca A, Frizziero M, Tariq NU, Hubner RA, Valle JW, Amir E, McNamara MG.

Int J Mol Sci. 2017 Apr 26;18(5). pii: E909. doi: 10.3390/ijms18050909. Review.

37.

68Gallium DOTANOC-PET Imaging in Lung Carcinoids: Impact on Patients' Management.

Lamarca A, Pritchard DM, Westwood T, Papaxoinis G, Nonaka D, Vinjamuri S, Valle JW, Manoharan P, Mansoor W.

Neuroendocrinology. 2018;106(2):128-138. doi: 10.1159/000472717. Epub 2017 Apr 12.

PMID:
28399530
38.

Reply: Rapid changes in practice make analysis of historical databases irrelevant for contemporary counselling.

Sunkara SK, LaMarca A, Polyzos NP, Seed PT, Khalaf Y.

Hum Reprod. 2017 Apr 1;32(4):964-965. doi: 10.1093/humrep/dex039. No abstract available.

PMID:
28333227
39.

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study.

Orkin C, DeJesus E, Ramgopal M, Crofoot G, Ruane P, LaMarca A, Mills A, Vandercam B, de Wet J, Rockstroh J, Lazzarin A, Rijnders B, Podzamczer D, Thalme A, Stoeckle M, Porter D, Liu HC, Cheng A, Quirk E, SenGupta D, Cao H.

Lancet HIV. 2017 May;4(5):e195-e204. doi: 10.1016/S2352-3018(17)30031-0. Epub 2017 Mar 2.

PMID:
28259777
40.

Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study.

DeJesus E, Ramgopal M, Crofoot G, Ruane P, LaMarca A, Mills A, Martorell CT, de Wet J, Stellbrink HJ, Molina JM, Post FA, Valero IP, Porter D, Liu Y, Cheng A, Quirk E, SenGupta D, Cao H.

Lancet HIV. 2017 May;4(5):e205-e213. doi: 10.1016/S2352-3018(17)30032-2. Epub 2017 Mar 2.

PMID:
28259776
41.

Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine Carcinomas.

Lamarca A, Walter T, Pavel M, Borbath I, Freis P, Nuñez B, Childs A, McNamara MG, Hubner RA, Garcia-Carbonero R, Meyer T, Valle JW, Barriuso J.

J Natl Cancer Inst. 2017 Jan 27;109(5). doi: 10.1093/jnci/djw277. Print 2017 Jan.

PMID:
28130474
42.

Elderly patients diagnosed with hepatopancreatobiliary malignancies: A challenge beyond resection.

Lamarca A, Pihlak R, Frizziero M, McNamara MG, Hubner RA, Valle JW.

Cancer. 2017 Mar 1;123(5):888-890. doi: 10.1002/cncr.30502. Epub 2017 Jan 6. No abstract available.

43.

HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?

Galdy S, Lamarca A, McNamara MG, Hubner RA, Cella CA, Fazio N, Valle JW.

Cancer Metastasis Rev. 2017 Mar;36(1):141-157. doi: 10.1007/s10555-016-9645-x. Review.

44.
45.

Evaluation of diagnostic and prognostic significance of Ki-67 index in pulmonary carcinoid tumours.

Clay V, Papaxoinis G, Sanderson B, Valle JW, Howell M, Lamarca A, Krysiak P, Bishop P, Nonaka D, Mansoor W.

Clin Transl Oncol. 2017 May;19(5):579-586. doi: 10.1007/s12094-016-1568-z. Epub 2016 Nov 15.

PMID:
27848218
46.

Telotristat ethyl: a new option for the management of carcinoid syndrome.

Lamarca A, Barriuso J, McNamara MG, Hubner RA, Valle JW.

Expert Opin Pharmacother. 2016 Dec;17(18):2487-2498. Epub 2016 Nov 16. Review.

PMID:
27817224
47.

Live birth and perinatal outcomes following stimulated and unstimulated IVF: analysis of over two decades of a nationwide data.

Sunkara SK, LaMarca A, Polyzos NP, Seed PT, Khalaf Y.

Hum Reprod. 2016 Oct;31(10):2261-7. doi: 10.1093/humrep/dew184. Epub 2016 Sep 2.

PMID:
27591229
48.

Prognostic factors for disease relapse in patients with neuroendocrine tumours who underwent curative surgery.

Slagter AE, Ryder D, Chakrabarty B, Lamarca A, Hubner RA, Mansoor W, O'Reilly DA, Fulford PE, Klümpen HJ, Valle JW, McNamara MG.

Surg Oncol. 2016 Sep;25(3):223-8. doi: 10.1016/j.suronc.2016.05.019. Epub 2016 May 26.

PMID:
27566026
49.

Identification of clinical biomarkers for patients with advanced hepatocellular carcinoma receiving sorafenib.

Lamarca A, Abdel-Rahman O, Salu I, McNamara MG, Valle JW, Hubner RA.

Clin Transl Oncol. 2017 Mar;19(3):364-372. doi: 10.1007/s12094-016-1537-6. Epub 2016 Aug 19.

PMID:
27541594
50.

Impact of biliary stent-related events in patients diagnosed with advanced pancreatobiliary tumours receiving palliative chemotherapy.

Lamarca A, Rigby C, McNamara MG, Hubner RA, Valle JW.

World J Gastroenterol. 2016 Jul 14;22(26):6065-75. doi: 10.3748/wjg.v22.i26.6065.

Supplemental Content

Loading ...
Support Center